| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,725 |
3,476 |
$239K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
20 |
12 |
$24K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
289 |
209 |
$23K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
33 |
32 |
$5K |
| 99215 |
Prolong outpt/office vis |
12 |
12 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14 |
13 |
$848.62 |
| J7050 |
Infusion, normal saline solution, 250 cc |
980 |
800 |
$334.80 |
| 96415 |
|
18 |
12 |
$153.87 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
44 |
39 |
$144.05 |